Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Classement en actions #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Prix de l'action
$0.04406501
Dernière synchronisation: 2024-07-09
Capitalisation boursière
$23.47M
Changement (1 jour)
-0.48%
Changement (1 an)
0.00%
Pays
SE
Échange InDex Pharmaceuticals Holding AB (publ) (INDEX)

Catégorie

Historique du prix de l'action pour InDex Pharmaceuticals Holding AB (publ) (INDEX)
Prix de clôture le plus élevé : $0.04 le 2024-07-01

Prix de clôture le plus bas : $0.27 le 2016-10-01
Historique du prix de l'action de InDex Pharmaceuticals Holding AB (publ) de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 87.14%
2023 -26.23%
2022 -50.30%
2021 -15.30%
2020 -67.25%
2019 -14.75%
2018 30.01%
2017 -11.67%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH